ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RZLT vs ASMB // DIVIDEND YIELD & FCF PAYOUT SAFETY

Rezolute Inc. (NV) (NASDAQ) VS. Assembly Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: RZLT 1 — ASMB 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RZLT VS. ASMB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RZLT ASMB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -6.50% -28.50 ASMB /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -17.33% -9.69% -7.64 ASMB /fcf-yield <GO>
Operating Margin — -16.80% — TIE /operating-margins <GO>
Net Profit Margin — -8.50% — TIE /net-margins <GO>
Revenue Growth (YoY) — 153.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 1.57 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 ASMB /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.9 35.9 +9.99 RZLT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $398.5M $424.7M -$26.2M ASMB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RZLT REV ASMB REV RZLT GROSS % ASMB GROSS % RZLT FCF ASMB FCF
FY 2025 $0 $72.3M — — -$69.1M -$41.2M
FY 2024 $0 $28.5M — — -$57.4M -$51.1M
FY 2023 $0 $0 — — -$44.5M $22.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RZLT // BETA —
ASMB // BETA —